Recent evidence however suggests that FOXO1, not FOXO3, acts as a “master regulator” driving MCL progression, with FOXO1 inducing the expression of genes governing MCL lineage survival (111). The gene discussed is FOXO3; the disease is mantle cell lymphoma.